1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
61D937F6908586A3C6525811D0041ABD1
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-market-research-vendor-management?opendocument
18
19opendocument
2034.229.24.100
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Competitive and Business Intelligence Contracting Vendor/ Outsourcing

Market Research Vendor Excellence: Exclusive Vendor Management

ID: 5459


Features:

11 Info Graphics

24 Data Graphics

130+ Metrics

1 Narratives


Pages/Slides: 49


Published: 2017


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Market Research Vendor Excellence: Exclusive Vendor Management”

STUDY OVERVIEW



To provide better services and support to their internal clients, market research groups within biopharmaceutical companies outsource some of their primary and secondary market research studies to external vendors. Oftentimes, market research groups prefer to work with exclusive vendors to attain greater work efficiency and reduce costs.

However, market researchers often struggle to strike the optimal balance between controlling vendor costs and delivering quality insights.

Best Practices, LLC undertook benchmarking research to explore well-established and emerging efficiencies and trends in exclusive vendor management, including: extent of outsourcing, managing exclusive vendor relationships, use and outsourcing of market research vendors, evaluation and return on investment, vendor management automation and key lessons learned.

KEY TOPICS

  • Extent of Outsourcing
  • Managing Exclusive Vendor Relationships
  • Use and Outsourcing of Market Research Vendors
  • Evaluation and Return on Investment
  • Vendor Management Automation
  • Lessons Learned

KEY METRICS

  • If your company does not have a VMO, who manages the exclusive vendor relationship within your internal market research group?
  • What types of training does your company employ when onboarding an exclusive vendor?
  • How has your use of an exclusive vendor model impacted employee engagement in your internal market research group?
  • If your company uses exclusive vendors, what percentage of primary market research is outsourced to them?
  • What types of partnership models do you utilize with your external vendors for market research?
  • Which of the following benefits and challenges, if any, did your company realize as a result of moving to an exclusive vendor for market research?
  • What metrics do you use to measure return on investment in your use of exclusive vendors?
  • What are you automating in vendor management?

SAMPLE KEY FINDINGS

  • Exclusive Vendors Used Across An Array of Market Research Studies: Companies contract exclusive vendors for different types of market research studies. Benchmark participants hire exclusive vendors for different types of primary market research studies including branding (75%), positioning (88%), competitive assessment (50%) and thought leader research (50%) studies.

METHODOLOGY


Best Practices, LLC engaged 16 Market Research and Business Intelligence leaders from 15 leading biotech and pharmaceutical companies through a benchmarking survey. More than 40% of research participants serve at the director level or higher.


Industries Profiled:
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Health Care; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
AstraZeneca; Bayer; Boehringer Ingelheim; EMD Serono; Janssen; Merck; Mylan; Nevakar; Pfizer; Sanofi; Stryker; Teva Pharmaceutical Industries Ltd; Upsher-Smith; Vifor Pharma; Japanese - HQ Development Stage Company

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.